These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23867179)

  • 1. Survey on the prevention and incidence of haemolytic disease of the newborn in Italy.
    Bennardello F; Curciarello G
    Blood Transfus; 2013 Oct; 11(4):518-27. PubMed ID: 23867179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey of the current use of anti-D immunoprophylaxis and the incidence of haemolytic disease of the newborn in Italy.
    Velati C
    Blood Transfus; 2007 Jan; 5(1):7-14. PubMed ID: 19204745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemolytic disease of the newborn infant. Long term efficiency of the screening and the prevention of alloimmunization in the mother: thirty years of experience.
    Moncharmont P; Juron Dupraz F; Vignal M; Rigal D; Meyer F; Debeaux P
    Arch Gynecol Obstet; 1991; 248(4):175-80. PubMed ID: 1910321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemolytic disease of newborn.
    Narang A; Jain N
    Indian J Pediatr; 2001 Feb; 68(2):167-72. PubMed ID: 11284186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional study of haemolytic disease of the newborn in Uganda.
    Dhabangi A; Nankunda J; Okaba V; Nakubulwa S; Hume HA; Dzik WH; Heddle NM
    Vox Sang; 2022 Dec; 117(12):1398-1404. PubMed ID: 36342344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual case of ABO-haemolytic disease of the newborn.
    Haque KM; Rahman M
    Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):61-4. PubMed ID: 11508073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility.
    Awad HA; Tantawy AA; El-Farrash RA; Ismail EA; Youssif NM
    Blood Transfus; 2014 Apr; 12(2):250-9. PubMed ID: 24333075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Rh antibodies in haemolytic disease of the newborn.
    Hadley AG; Kumpel BM
    Baillieres Clin Haematol; 1993 Jun; 6(2):423-44. PubMed ID: 8043933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune cytopenias in newborns].
    Brossard Y
    Rev Prat; 2001 Sep; 51(14):1571-6. PubMed ID: 11757274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of immunoglobulins in neonatal Rhesus haemolytic disease.
    Greenough A
    BioDrugs; 2001; 15(8):533-41. PubMed ID: 11543694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory identification of erythroblastosis fetalis.
    Kurtz EM; Pappas AA; Cannon A
    Ann Clin Lab Sci; 1982; 12(5):388-97. PubMed ID: 6814344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in feto-maternal incompatibility and the indications for exchange transfusion].
    Serrano J
    Sangre (Barc); 1991 Dec; 36(6):471-6. PubMed ID: 1667442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Foetal-maternal alloimmunizations in the South-East area of the Venice province].
    Gessoni G; Valverde S; Giacomini A; Antico F; Salvadego M; Arreghini N; De Fusco G; Fezzi M; Marchiori G; Manoni F
    Minerva Ginecol; 2002 Aug; 54(4):333-8. PubMed ID: 12114866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemolytic disease of the newborn in Western Australia 1974 to 1976.
    Vieira BI; Murdock CJ; Hendry PJ; Stanley F; Davey MG
    Aust N Z J Obstet Gynaecol; 1980 May; 20(2):69-72. PubMed ID: 6774705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population in Taiwan.
    Wu KH; Chu SL; Chang JG; Shih MC; Peng CT
    Transfus Med; 2003 Oct; 13(5):311-4. PubMed ID: 14617342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG1 and IgG3 anti-D in maternal serum and on the RBCs of infants suffering from HDN: relationship with the severity of the disease.
    Lambin P; Debbia M; Puillandre P; Brossard Y
    Transfusion; 2002 Dec; 42(12):1537-46. PubMed ID: 12473131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling Rh haemolytic disease of the newborn in India.
    Joseph KS
    Br J Obstet Gynaecol; 1991 Apr; 98(4):369-77. PubMed ID: 1851635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden.
    Filbey D; Hanson U; Wesström G
    Acta Obstet Gynecol Scand; 1995 Oct; 74(9):687-92. PubMed ID: 7572101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O mother.
    Drabik-Clary K; Reddy VV; Benjamin WH; Boctor FN
    Ann Clin Lab Sci; 2006; 36(2):205-7. PubMed ID: 16682519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.